002581 未名医药
午间休市 12-20 11:30:00
资讯
新帖
简况
未名医药最新公告：转让参股公司营口化工26.8380%股权征集到意向受让方
证券之星 · 12-06
未名医药最新公告：转让参股公司营口化工26.8380%股权征集到意向受让方
未名医药(002581.SZ)聘任周婷为财务总监
智通财经 · 12-05
未名医药(002581.SZ)聘任周婷为财务总监
异动快报：未名医药（002581）12月3日10点36分触及涨停板
证券之星 · 12-03
异动快报：未名医药（002581）12月3日10点36分触及涨停板
未名医药(002581.SZ)拟推2024年股票期权激励计划 行权价每股12.35元
智通财经 · 12-02
未名医药(002581.SZ)拟推2024年股票期权激励计划 行权价每股12.35元
未名医药因信息披露涉嫌违法违规被行政处罚！
市场资讯 · 11-26
未名医药因信息披露涉嫌违法违规被行政处罚！
未名医药借壳上市9年从未分红 销售费占营收61%研发人员4年减半
长江商报 · 11-21
未名医药借壳上市9年从未分红 销售费占营收61%研发人员4年减半
未名医药最新公告：拟7402.54万元转让参股公司营口化工26.84%股权
证券之星 · 11-19
未名医药最新公告：拟7402.54万元转让参股公司营口化工26.84%股权
未名医药（002581）11月18日主力资金净卖出2244.96万元
证券之星 · 11-19
未名医药（002581）11月18日主力资金净卖出2244.96万元
未名医药（002581）11月14日主力资金净买入1472.51万元
证券之星 · 11-15
未名医药（002581）11月14日主力资金净买入1472.51万元
未名医药（002581）10月31日主力资金净买入7123.16万元
证券之星 · 11-01
未名医药（002581）10月31日主力资金净买入7123.16万元
10月31日未名医药涨停分析：高校系，新冠疫苗，眼科概念热股
证券之星 · 10-31
10月31日未名医药涨停分析：高校系，新冠疫苗，眼科概念热股
异动快报：未名医药（002581）10月31日9点54分触及涨停板
证券之星 · 10-31
异动快报：未名医药（002581）10月31日9点54分触及涨停板
未名医药(002581.SZ)发布前三季度业绩，净利润1462.63万元，同比下降50.78%
智通财经 · 10-30
未名医药(002581.SZ)发布前三季度业绩，净利润1462.63万元，同比下降50.78%
10月25日未名医药现1笔大宗交易 机构净买入2999.65万元
证券之星 · 10-25
10月25日未名医药现1笔大宗交易 机构净买入2999.65万元
未名医药（002581）10月24日主力资金净买入1826.47万元
证券之星 · 10-25
未名医药（002581）10月24日主力资金净买入1826.47万元
异动快报：未名医药（002581）10月24日10点14分触及涨停板
证券之星 · 10-24
异动快报：未名医药（002581）10月24日10点14分触及涨停板
10月23日未名医药涨停分析：眼科，高校系，疫苗概念热股
证券之星 · 10-23
10月23日未名医药涨停分析：眼科，高校系，疫苗概念热股
异动快报：未名医药（002581）10月23日14点4分触及涨停板
证券之星 · 10-23
异动快报：未名医药（002581）10月23日14点4分触及涨停板
未名医药（002581）10月21日主力资金净卖出1513.98万元
证券之星 · 10-22
未名医药（002581）10月21日主力资金净卖出1513.98万元
持续亏损的未名医药急于脱手盈利子公司，三度降价求买主
第一财经 · 10-18
持续亏损的未名医药急于脱手盈利子公司，三度降价求买主
加载更多
公司概况
公司名称：
山东未名生物医药股份有限公司
所属行业：
医药制造业
上市日期：
2011-05-20
主营业务：
山东未名生物医药股份有限公司主营业务为为干扰素、神经生长因子、生物医药CRO/CDMO、疫苗和医药中间体等五大生物医药板块。主要产品有鼠神经生长因子、干扰素、技术服务。公司子公司天津未名是我国率先进入基因工程制药产业化领域的企业之一。重点发展人干扰素α2b系列产品，主要产品捷抚-重组人干扰素α2b喷雾剂（假单胞菌），是全球第一支干扰素喷雾剂。
发行价格：
19.00
{"stockData":{"symbol":"002581","market":"SZ","secType":"STK","nameCN":"未名医药","latestPrice":12.39,"timestamp":1734668718000,"preClose":12.38,"halted":0,"volume":2744900,"delay":0,"floatShares":401000000,"shares":660000000,"eps":-0.5268,"marketStatus":"午间休市","marketStatusCode":3,"change":0.01,"latestTime":"12-20 11:30:00","open":12.38,"high":12.49,"low":12.22,"amount":33911800,"amplitude":0.0218,"askPrice":12.39,"askSize":52,"bidPrice":12.38,"bidSize":171,"shortable":0,"etf":0,"ttmEps":-0.5268,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734670800000},"adr":0,"adjPreClose":12.38,"symbolType":"stock","openAndCloseTimeList":[[1734658200000,1734665400000],[1734670800000,1734678000000]],"highLimit":13.62,"lowLimit":11.14,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":659735586,"pbRate":3.91,"roa":"--","roe":"0.7%","epsLYR":-0.5039,"committee":0.202226,"marketValue":8174000000,"floatMarketCap":4966000000,"peRate":-23.519363,"changeRate":0.0008,"turnoverRate":0.0068,"status":0},"requestUrl":"/m/hq/s/002581","defaultTab":"news","newsList":[{"id":"2489016664","title":"未名医药最新公告：转让参股公司营口化工26.8380%股权征集到意向受让方","url":"https://stock-news.laohu8.com/highlight/detail?id=2489016664","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489016664?lang=zh_cn&edition=full","pubTime":"2024-12-06 17:39","pubTimestamp":1733477982,"startTime":"0","endTime":"0","summary":"未名医药公告，公司全资子公司未名天源在山东产权交易中心通过公开挂牌方式出售营口化工26.8380%股权，交易价格为7402.54万元。截止未名天源所持有的营口化工26.8380%股权第四次挂牌日期届满，公司收到山东产权交易中心通知，本次挂牌转让共征集到1个符合受让条件的意向受让方。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120600031732.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","BK0046","BK0197","002581","BK0042"],"gpt_icon":0},{"id":"2489455589","title":"未名医药(002581.SZ)聘任周婷为财务总监","url":"https://stock-news.laohu8.com/highlight/detail?id=2489455589","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489455589?lang=zh_cn&edition=full","pubTime":"2024-12-05 20:51","pubTimestamp":1733403100,"startTime":"0","endTime":"0","summary":"智通财经APP讯，未名医药(002581.SZ)发布公告，公司董事会于近日收到公司财务总监刘阳军先生提交的书面辞职报告，因个人原因，申请辞去公司财务总监职务，辞职后将不在公司及控股子公司担任任何职务。公司于2024年12月4日召开了第五届董事会第三十次会议，审议通过了《关于聘任财务总监的议案》，为保障公司财务工作的合规运行、有序管理，经公司总经理提名、审计委员会审核、提名委员会资格审查、公司董事会审议通过，同意聘任周婷女士为公司财务总监，任期自第五届董事会第三十次会议审议通过之日起至第五届董事会届满之日止。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1221082.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0077","002581","BK0197","BK0042","BK0046","BK0239"],"gpt_icon":0},{"id":"2488932897","title":"异动快报：未名医药（002581）12月3日10点36分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2488932897","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488932897?lang=zh_cn&edition=full","pubTime":"2024-12-03 10:40","pubTimestamp":1733193632,"startTime":"0","endTime":"0","summary":"证券之星12月3日盘中消息，10点36分未名医药（002581）触及涨停板。目前价格13.49，上涨10.03%。其所属行业生物制品目前下跌。领涨股为未名医药。该股为高校系，眼科，新冠疫苗概念热股，当日高校系概念上涨0.55%，眼科概念上涨0.05%。12月2日的资金流向数据方面，主力资金净流出382.55万元，占总成交额5.03%，游资资金净流入77.03万元，占总成交额1.01%，散户资金净流入305.52万元，占总成交额4.02%。近5日资金流向一览见下表：未名医药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120300013978.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","BK0042","BK0239","BK0077","002581","BK0046"],"gpt_icon":0},{"id":"2488672886","title":"未名医药(002581.SZ)拟推2024年股票期权激励计划 行权价每股12.35元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488672886","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488672886?lang=zh_cn&edition=full","pubTime":"2024-12-02 22:31","pubTimestamp":1733149898,"startTime":"0","endTime":"0","summary":"智通财经APP讯，未名医药(002581.SZ)发布2024年股票期权激励计划(草案)，本计划授予的股票期权所涉及的标的股票总数为1963.46万股，占本激励计划草案公告时公司股本总额的2.98%。本激励计划授予的激励对象共计100人，本计划授予的股票期权的行权价格为每股12.35元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1219366.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0077","002581","BK0197","BK0239","BK0046","BK0042"],"gpt_icon":0},{"id":"2486301610","title":"未名医药因信息披露涉嫌违法违规被行政处罚！","url":"https://stock-news.laohu8.com/highlight/detail?id=2486301610","media":"市场资讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486301610?lang=zh_cn&edition=full","pubTime":"2024-11-26 11:41","pubTimestamp":1732592460,"startTime":"0","endTime":"0","summary":" 按照申万行业分类，未名医药（维权）属于医药生物-生物制品-其他生物制品。 2023年11月21日，公司收到证监会出具的《立案告知书》，因信息披露涉嫌违法违规。经查明，未名医药存在以下违法事实：。 增资协议属于未名医药订立的重要合同，厦门未名变更工商登记属于合同履行的重大进展，未名医药应当及时予以披露，但未按规定披露。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-11-26/doc-incxkhun8058034.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0077","002581","BK0197","BK0042","BK0046","BK0239"],"gpt_icon":0},{"id":"2485910458","title":"未名医药借壳上市9年从未分红 销售费占营收61%研发人员4年减半","url":"https://stock-news.laohu8.com/highlight/detail?id=2485910458","media":"长江商报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485910458?lang=zh_cn&edition=full","pubTime":"2024-11-21 08:44","pubTimestamp":1732149840,"startTime":"0","endTime":"0","summary":"近年来，未名医药业绩并不理想，2024年前三季度，公司实现营业收入3.15亿元，同比下降6.99%；净利润1462.63万元，同比下降50.78%。未名医药表示，本次交易完成后，公司将不再持有营口化工股权。需要注意的是，近年来，未名医药销售费用虽在下滑，但占营收比例却不低。2024年前三季度，未名医药销售费用达1.91亿元，同比下降10.66%，占同期营业收入61%。而且自2016年以来，也就是未名医药借壳上市后，公司再未进行过分红，至今已有9年。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-11-21/doc-incwusvu1480513.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["002581"],"gpt_icon":0},{"id":"2484919571","title":"未名医药最新公告：拟7402.54万元转让参股公司营口化工26.84%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2484919571","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484919571?lang=zh_cn&edition=full","pubTime":"2024-11-19 18:29","pubTimestamp":1732012182,"startTime":"0","endTime":"0","summary":"未名医药公告，公司在山东产权交易中心通过公开挂牌方式出售公司全资子公司未名天源持有的营口化工26.8380%股权。近日，未名天源与营口盛海、美联新材、营口化工就本次拟转让参股公司股权事项签署了《关于营口营新化工科技有限公司之股权转让协议》，转让价格为7402.54万元。本次交易完成后，公司将不再持有营口化工股权。本次交易符合公司目前经营情况及发展战略规划，有利于优化资产结构。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111900030834.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002581","BK0239","BK0077","BK0042","BK0197","BK0046"],"gpt_icon":0},{"id":"2484588819","title":"未名医药（002581）11月18日主力资金净卖出2244.96万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484588819","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484588819?lang=zh_cn&edition=full","pubTime":"2024-11-19 09:24","pubTimestamp":1731979444,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年11月18日收盘，未名医药报收于12.5元，下跌7.54%，换手率3.52%，成交量14.09万手，成交额1.81亿元。11月18日的资金流向数据方面，主力资金净流出2244.96万元，占总成交额12.43%，游资资金净流入885.16万元，占总成交额4.9%，散户资金净流入1359.79万元，占总成交额7.53%。未名医药主营业务：医药制造及CDMO生物医药代研发、代生产服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111900008320.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002581","BK0077","BK0046","BK0197","BK0042"],"gpt_icon":0},{"id":"2483369352","title":"未名医药（002581）11月14日主力资金净买入1472.51万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483369352","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483369352?lang=zh_cn&edition=full","pubTime":"2024-11-15 09:11","pubTimestamp":1731633089,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年11月14日收盘，未名医药报收于13.51元，上涨4.24%，换手率4.69%，成交量18.81万手，成交额2.54亿元。11月14日的资金流向数据方面，主力资金净流入1472.51万元，占总成交额5.79%，游资资金净流出40.07万元，占总成交额0.16%，散户资金净流出1432.44万元，占总成交额5.63%。融券方面，融券卖出7400.0股，融券偿还1300.0股，融券余量2.9万股，融券余额39.18万元。未名医药主营业务：医药制造及CDMO生物医药代研发、代生产服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111500007427.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","BK0239","002581","BK0042","BK0077","BK0046"],"gpt_icon":0},{"id":"2480016360","title":"未名医药（002581）10月31日主力资金净买入7123.16万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480016360","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480016360?lang=zh_cn&edition=full","pubTime":"2024-11-01 09:11","pubTimestamp":1730423511,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年10月31日收盘，未名医药报收于11.95元，上涨10.04%，涨停，换手率5.26%，成交量21.09万手，成交额2.47亿元。近5日资金流向一览见下表：未名医药融资融券信息显示，融资方面，当日融资买入2541.0万元，融资偿还1458.02万元，融资净买入1082.97万元。未名医药主营业务：医药制造及CDMO生物医药代研发、代生产服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110100010371.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002581","BK0239","BK0077","BK0042","BK0197","BK0046"],"gpt_icon":0},{"id":"2479738597","title":"10月31日未名医药涨停分析：高校系，新冠疫苗，眼科概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2479738597","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479738597?lang=zh_cn&edition=full","pubTime":"2024-10-31 15:58","pubTimestamp":1730361486,"startTime":"0","endTime":"0","summary":"证券之星消息，未名医药10月31日涨停收盘，收盘价11.95元。该股于9点54分涨停，2次打开涨停，截止收盘封单资金为2674.59万元，占其流通市值0.56%。10月31日的资金流向数据方面，主力资金净流入7123.16万元，占总成交额28.85%，游资资金净流出2964.96万元，占总成交额12.01%，散户资金净流出4158.21万元，占总成交额16.84%。近5日资金流向一览见下表：该股为高校系，新冠疫苗，眼科概念热股，当日高校系概念上涨1.61%，新冠疫苗概念上涨1.2%，眼科概念上涨1.12%。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100029557.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159646","BK0077","002581","BK0042","BK0239","BK0046","BK0197"],"gpt_icon":0},{"id":"2479163067","title":"异动快报：未名医药（002581）10月31日9点54分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2479163067","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479163067?lang=zh_cn&edition=full","pubTime":"2024-10-31 09:55","pubTimestamp":1730339732,"startTime":"0","endTime":"0","summary":"证券之星10月31日盘中消息，9点54分未名医药触及涨停板。目前价格11.95，上涨10.04%。该股为高校系，新冠病毒防治，眼科概念热股，当日高校系概念上涨0.78%，新冠病毒防治概念上涨0.61%，眼科概念上涨0.39%。近5日资金流向一览见下表：未名医药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100014974.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0197","BK0077","BK0042","BK0046","002581"],"gpt_icon":0},{"id":"2479336142","title":"未名医药(002581.SZ)发布前三季度业绩，净利润1462.63万元，同比下降50.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479336142","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479336142?lang=zh_cn&edition=full","pubTime":"2024-10-30 00:00","pubTimestamp":1730217643,"startTime":"0","endTime":"0","summary":"智通财经APP讯，未名医药(002581.SZ)发布2024年三季度报告，前三季度，公司实现营业收入3.15亿元，同比下降6.99%。归属于上市公司股东的净利润1462.63万元，同比下降50.78%。归属于上市公司股东的扣除非经常性损益的净利润1657.06万元，同比下降49.02%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1203186.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002581"],"gpt_icon":0},{"id":"2478608547","title":"10月25日未名医药现1笔大宗交易 机构净买入2999.65万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478608547","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478608547?lang=zh_cn&edition=full","pubTime":"2024-10-25 16:50","pubTimestamp":1729846254,"startTime":"0","endTime":"0","summary":"证券之星消息，10月25日未名医药发生大宗交易，交易数据如下：大宗交易成交价格11.38元，成交263.59万股，成交金额2999.65万元，买方营业部为机构专用，卖方营业部为华福证券有限责任公司慈溪新城大道北路证券营业部。近三个月该股共发生1笔大宗交易，合计成交2.64万手。该股近期无解禁股上市。截至2024年10月25日收盘，未名医药(002581)报收于11.38元，下跌3.89%，换手率6.01%，成交量24.07万手，成交额2.71亿元。该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102500027676.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","BK0046","BK0197","002581","BK0042"],"gpt_icon":0},{"id":"2478644617","title":"未名医药（002581）10月24日主力资金净买入1826.47万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478644617","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478644617?lang=zh_cn&edition=full","pubTime":"2024-10-25 09:11","pubTimestamp":1729818713,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年10月24日收盘，未名医药报收于11.84元，上涨9.43%，换手率9.45%，成交量37.86万手，成交额4.34亿元。10月24日的资金流向数据方面，主力资金净流入1826.47万元，占总成交额4.21%，游资资金净流入1969.13万元，占总成交额4.54%，散户资金净流出3795.61万元，占总成交额8.75%。未名医药主营业务：医药制造及CDMO生物医药代研发、代生产服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102500008791.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0042","002581","BK0197","BK0239","BK0046"],"gpt_icon":0},{"id":"2477439548","title":"异动快报：未名医药（002581）10月24日10点14分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2477439548","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477439548?lang=zh_cn&edition=full","pubTime":"2024-10-24 10:15","pubTimestamp":1729736143,"startTime":"0","endTime":"0","summary":"证券之星10月24日盘中消息，10点14分未名医药（002581）触及涨停板。目前价格11.9，上涨9.98%。其所属行业生物制品目前上涨。领涨股为我武生物。该股为疫苗，医药，创新药概念热股，当日疫苗概念上涨1.53%，医药概念上涨1.02%，创新药概念上涨0.87%。10月23日的资金流向数据方面，主力资金净流入2203.38万元，占总成交额13.51%，游资资金净流出1331.67万元，占总成交额8.16%，散户资金净流出871.71万元，占总成交额5.34%。近5日资金流向一览见下表：未名医药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102400011449.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","002581","BK0042","BK0239","BK0046","BK0197"],"gpt_icon":0},{"id":"2477379983","title":"10月23日未名医药涨停分析：眼科，高校系，疫苗概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2477379983","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477379983?lang=zh_cn&edition=full","pubTime":"2024-10-23 15:38","pubTimestamp":1729669123,"startTime":"0","endTime":"0","summary":"证券之星消息，未名医药10月23日涨停收盘，收盘价10.82元。该股于14点4分涨停，未打开涨停，截止收盘封单资金为3551.66万元，占其流通市值0.82%。10月23日的资金流向数据方面，主力资金净流入2203.38万元，占总成交额13.51%，游资资金净流出1331.67万元，占总成交额8.16%，散户资金净流出871.71万元，占总成交额5.34%。近5日资金流向一览见下表：该股为眼科，高校系，疫苗概念热股，当日眼科概念上涨0.65%，高校系概念上涨0.64%，疫苗概念上涨0.34%。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102300021577.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159646","BK0197","BK0239","BK0042","BK0046","002581","BK0077"],"gpt_icon":0},{"id":"2477220703","title":"异动快报：未名医药（002581）10月23日14点4分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2477220703","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477220703?lang=zh_cn&edition=full","pubTime":"2024-10-23 14:05","pubTimestamp":1729663524,"startTime":"0","endTime":"0","summary":"证券之星10月23日盘中消息，14点4分未名医药（002581）触及涨停板。目前价格10.82，上涨9.96%。其所属行业生物制品目前上涨。领涨股为万泽股份。该股为高校系，眼科，疫苗概念热股，当日高校系概念上涨0.8%，眼科概念上涨0.46%，疫苗概念上涨0.46%。10月23日的资金流向数据方面，主力资金净流出516.95万元，占总成交额9.19%，游资资金净流入49.26万元，占总成交额0.88%，散户资金净流入467.7万元，占总成交额8.31%。近5日资金流向一览见下表：未名医药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102300018701.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","BK0046","BK0197","002581","BK0042"],"gpt_icon":0},{"id":"2477182383","title":"未名医药（002581）10月21日主力资金净卖出1513.98万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477182383","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477182383?lang=zh_cn&edition=full","pubTime":"2024-10-22 09:24","pubTimestamp":1729560274,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年10月21日收盘，未名医药报收于9.9元，下跌1.2%，换手率2.63%，成交量10.54万手，成交额1.05亿元。10月21日的资金流向数据方面，主力资金净流出1513.98万元，占总成交额14.35%，游资资金净流入547.07万元，占总成交额5.19%，散户资金净流入966.91万元，占总成交额9.17%。融券方面，融券卖出1400.0股，融券偿还2.02万股，融券余量1.5万股，融券余额14.85万元。未名医药主营业务：医药制造及CDMO生物医药代研发、代生产服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102200007483.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002581","BK0077","BK0046","BK0197","BK0042"],"gpt_icon":0},{"id":"2476785254","title":"持续亏损的未名医药急于脱手盈利子公司，三度降价求买主","url":"https://stock-news.laohu8.com/highlight/detail?id=2476785254","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476785254?lang=zh_cn&edition=full","pubTime":"2024-10-18 21:50","pubTimestamp":1729259400,"startTime":"0","endTime":"0","summary":"两个半月的时间，三次打折降价，未名医药拟转让参股公司股权一事依然未获实质性进展。 10月17日晚间，未名医药披露，截止挂牌日期届满，根据山东产权交易中心向公司出具的《结果通知单》，拟转让参股公司营口营新化工科技有限公司的26.8380%股权事项，在第三轮正式挂牌中仍未征集到符合条件的意向受让方。 8月1日晚间，未名医药首次披露了拟转让该标的资产的公告。而出售方未名医药则处于持续亏损状态。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-10-18/doc-incsywqv1558673.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-10-18/doc-incsywqv1558673.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["002581","BK0197","BK0077","BK0046","BK0042","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2011-05-20","address":"山东省淄博市张店区淄博科技工业园南支一路(兴园路)28号","stockEarnings":[{"period":"1week","weight":-0.0642},{"period":"1month","weight":-0.019},{"period":"3month","weight":0.519},{"period":"6month","weight":0.238},{"period":"1year","weight":-0.1456},{"period":"ytd","weight":-0.1521}],"companyName":"山东未名生物医药股份有限公司","boardCode":"AI0027","perCapita":"11707股","boardName":"医药制造业","registeredCapital":"65973万元","compareEarnings":[{"period":"1week","weight":-0.0264},{"period":"1month","weight":0.0072},{"period":"3month","weight":0.2314},{"period":"6month","weight":0.124},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1328}],"survey":" 山东未名生物医药股份有限公司主营业务为为干扰素、神经生长因子、生物医药CRO/CDMO、疫苗和医药中间体等五大生物医药板块。主要产品有鼠神经生长因子、干扰素、技术服务。公司子公司天津未名是我国率先进入基因工程制药产业化领域的企业之一。重点发展人干扰素α2b系列产品，主要产品捷抚-重组人干扰素α2b喷雾剂（假单胞菌），是全球第一支干扰素喷雾剂。","serverTime":1734668726422,"listedPrice":19,"stockholders":"34233人(较上一季度增加0.69%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"未名医药(002581)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供未名医药(002581)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"未名医药,002581,未名医药股票,未名医药股票老虎,未名医药股票老虎国际,未名医药行情,未名医药股票行情,未名医药股价,未名医药股市,未名医药股票价格,未名医药股票交易,未名医药股票购买,未名医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"未名医药(002581)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供未名医药(002581)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}